XENE

Xenon Pharmaceuticals Inc.

Price

$34.45

return (12m)

-17.26%

p/e

-8.17

p/bv

2.69

DIVIDEND YIELD

0.00%

XENE price

Xenon Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment XENE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-11.45%

3 months

-48.11%

1 year

-17.26%

2 years

-23.22%

5 years

15.55%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals XENE

Valuation

P/E

-8.17

Sector -3.10

Industry -3.10

P/BV

2.69

Sector 1.77

Industry 1.77

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

-19.67

Sector -216.68

Industry -216.68

EV/EBIT

-19.58

Sector -46.14

Industry -46.14

P/EBITDA

-7.61

Sector -21.54

Industry -21.54

P/EBIT

-7.57

Sector -27.94

Industry -27.94

P/Total Assets

2.58

Sector 1.05

Industry 1.05

P/Net Current Assets

3.74

Sector -9.24

Industry -9.24

P/Working Capital

3.71

Sector -135.45

Industry -135.45

EPS

-4.11

Sector -1.78

Industry -1.78

BVPS

12.47

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

0.00%

Sector 41.24%

Industry 41.24%

EBITDA Margin

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

0.00%

Sector -35.37%

Industry -35.37%

Net Profit Margins

0.00%

Sector -35.81%

Industry -35.81%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-32.94%

Sector -57.47%

Industry -57.47%

ROA

-31.58%

Sector -59.48%

Industry -59.48%

ROIC

-150.40%

Sector -2,385.22%

Industry -2,385.22%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

21.02

Sector 2.92

Industry 2.92

Net Debt / EBITDA

7.59

Sector -21.38

Industry -21.38

Net Debt / EBIT

7.56

Sector -8.29

Industry -8.29

Net Debt / Equity

-0.75

Sector -33,113.00

Industry -33,113.00

Gross Debt / Equity

0.00

Sector -0.84

Industry -0.84

Equity/Assets

0.96

Sector 0.46

Industry 0.46

Liabilities/Assets

0.04

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

38.99%

Sector -

Industry -

Fundamentals XENE

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
XENE Xenon Pharmaceuticals Inc.	$34.45	-17.26%	0.00%	-8.17	2.69	-32.94%	0.00%
PFE Pfizer Inc.	$29.30	29.93%	5.91%	38.29	1.94	5.07%	6.80%
ABBV AbbVie Inc.	$283.02	27.22%	2.40%	79.71	-84.84	-106.44%	9.81%
NVO Novo Nordisk A/S	$38.44	-25.78%	4.74%	9.57	5.08	53.11%	35.32%
MRK Merck & Co. Inc.	$144.69	75.65%	2.34%	113.15	8.55	7.56%	4.77%
AZN AstraZeneca PLC	$165.06	-0.87%	1.95%	19.76	5.09	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$58.66	42.28%	4.19%	13.18	5.48	41.59%	18.87%
ZTS Zoetis Inc.	$79.45	-43.79%	2.64%	12.52	10.49	83.77%	27.69%
AMGN Amgen Inc.	$426.52	46.68%	2.29%	26.86	20.10	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$782.52	35.91%	0.47%	18.88	2.58	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$122.82	83.23%	0.00%	34.40	99.12	288.13%	24.86%
MCK McKesson Corporation	$994.67	27.04%	0.34%	25.91	-30.79	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$502.58	20.58%	0.00%	29.00	6.31	21.76%	35.00%
CAH Cardinal Health Inc.	$250.05	61.38%	0.81%	34.89	-21.95	-62.92%	0.67%
ARGX argenx SE	$820.58	-2.74%	0.00%	13.83	3.67	26.52%	25.54%
HRMY Harmony Biosciences Holdings Inc.	$37.50	44.79%	0.00%	12.22	2.22	18.14%	18.88%
BIIB Biogen Inc.	$232.87	62.85%	0.00%	41.65	1.84	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

XENE - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Xenon Pharmaceuticals

Xenon Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

Canada

30 years

Founded: 1996

2014

Time since IPO - 12 years

358

Employees

Xenon Pharmaceuticals Inc. (Canada) is listed on the Nasdaq and has a market capitalization of $3.34 billion, with shareholders equity totaling $1.24 billion.

The company employs approximately 358 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Xenon Pharmaceuticals Inc. reported $- in revenue, generating net income of $-409.20 million.

Key financial metrics include a P/E ratio of -8.17, a price-to-book (P/B) ratio of 2.69, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker XENE.

Market cap

$3.34 billion

Net worth

$1.24 billion

$1,242,396,000.00

Assets

$1.30 billion

$1,295,772,000.00

Total Shares Outstanding

99.61 million

99,609,000

Average Daily Trading Volume

$1.65 million

$1,651,118.00

Sector

Health Care

Industry

Biotechnology

XENE

XENE revenue and profits

Financial Results XENE

DRAG THE FRAME TO SEE MORE DATA

XENE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$994.67 27,04% (12M)

P/E

25.91

0.34%

ROE

-118.84%

P/BV

-30.79

CAH - Cardinal Health

$250.05 61,38% (12M)

P/E

34.89

0.81%

ROE

-62.92%

P/BV

-21.95

ABBV - AbbVie

$283.02 27,22% (12M)

P/E

79.71

2.40%

ROE

-106.44%

P/BV

-84.84

MRK - Merck & Co.

$144.69 75,65% (12M)

P/E

113.15

2.34%

ROE

7.56%

P/BV

8.55

AZN - AstraZeneca

$165.06 0,10% (12M)

P/E

19.76

1.95%

ROE

25.77%

P/BV

5.09

PFE - Pfizer

$29.30 29,93% (12M)

P/E

38.29

5.91%

ROE

5.07%

P/BV

1.94

BMY - Bristol-Myers Squibb

$58.66 42,28% (12M)

P/E

13.18

4.19%

ROE

41.59%

P/BV

5.48

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$994.67 27,04% (12 M)

P/L

25.91

0.34%

ROE

-118.84%

P/VP

-30.79

CAH - Cardinal Health

$250.05 61,38% (12 M)

P/L

34.89

0.81%

ROE

-62.92%

P/VP

-21.95

ABBV - AbbVie

$283.02 27,22% (12 M)

P/L

79.71

2.40%

ROE

-106.44%

P/VP

-84.84

MRK - Merck & Co.

$144.69 75,65% (12 M)

P/L

113.15

2.34%

ROE

7.56%

P/VP

8.55

AZN - AstraZeneca

$165.06 0,10% (12 M)

P/L

19.76

1.95%

ROE

25.77%

P/VP

5.09

PFE - Pfizer

$29.30 29,93% (12 M)

P/L

38.29

5.91%

ROE

5.07%

P/VP

1.94

BMY - Bristol-Myers Squibb

$58.66 42,28% (12 M)

P/L

13.18

4.19%

ROE

41.59%

P/VP

5.48

Frequently Asked Questions

What is the price of Xenon Pharmaceuticals (XENE) today?

The current price of Xenon Pharmaceuticals (XENE) is $34.45. The stock began the year trading around $44.82 and is currently priced at $34.45. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Xenon Pharmaceuticals (XENE) pay dividends?

Xenon Pharmaceuticals (XENE) did not pay dividends over the past year.

Is Xenon Pharmaceuticals (XENE) a good investment?

Xenon Pharmaceuticals (XENE) is currently trading at $34.45 with a P/E ratio of -8.17. This represents a -1,389% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -17.26%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Xenon Pharmaceuticals (XENE) stock?

You can buy Xenon Pharmaceuticals (XENE) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol XENE and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Xenon Pharmaceuticals (XENE) yield today?

Over the past month, Xenon Pharmaceuticals (XENE) has returned -11.45% — -17.26% over the past year, and 15.55% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Xenon Pharmaceuticals (XENE) today at the current price of $34.45 your total investment would be $3,444.50.

Based on historical performance, the investment would have grown to approximately:

$2,849.98 after 1 year
$3,980.12 after 5 years
$3,444.50 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

XENE

Xenon Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment XENE

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING XENE WITH OTHER STOCK

ABOUT Xenon Pharmaceuticals

Xenon Pharmaceuticals Inc.

Canada

30 years

2014

358

PROFIT X PRICE XENE

Financial Results XENE

XENE cash flow

Asset, Revenue and Profit Growth - XENE

XENE balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions